| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 38,929 | |||
| Accounts receivable, net | 224,943 | |||
| Inventories | 364,355 | |||
| Prepaid expenses and other current assets | 33,931 | |||
| Total current assets | 662,158 | |||
| Property, plant and equipment, net | 112,036 | |||
| Goodwill | 806,916 | |||
| Other intangible assets, net | 593,107 | |||
| Other assets | 148,271 | |||
| Total assets | 2,322,488 | |||
| Current portion of long-term debt | 746 | |||
| Accounts payable | 107,087 | |||
| Accrued compensation and benefits | 76,125 | |||
| Other current liabilities | 130,741 | |||
| Total current liabilities | 314,699 | |||
| Long-term debt | 853,007 | |||
| Deferred income taxes | 74,857 | |||
| Other long-term liabilities | 71,662 | |||
| Total liabilities | 1,314,225 | |||
| Preferred stock, par value .01 per share authorized 500,000 shares none outstanding | 0 | |||
| Common stock, par value 0.01 per share 100,000,000 shares authorized 31,299,194 shares issued in 2025 and 2024, respectively | 313 | |||
| Paid-in capital | 498,672 | |||
| Retained earnings | 572,027 | |||
| Accumulated other comprehensive loss | -49,232 | |||
| Less 344,143 and 397,860 shares of common stock in treasury, at cost, in 2025 and 2024, respectively | 13,517 | |||
| Total shareholders equity | 1,008,263 | |||
| Total liabilities and shareholders equity | 2,322,488 | |||
CONMED Corp (CNMD)
CONMED Corp (CNMD)